(Q44233666)

1 December 2017

title

Placebo practice trials: the best predictor of adherence readiness for HAART among drug users? (English)

1 reference

1 December 2017

1 reference

Glenn Wagner

1

1 reference

1 December 2017

publication date

1 July 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

4

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

269-281

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Predicting the unpredictable: transmission of drug-resistant HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Nutritional assessment of drug addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Factors affecting adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Self-reported antiretroviral therapy in injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Barriers to use of free antiretroviral therapy in injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Provider assessment of adherence to HIV antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

A motivational intervention to improve adherence to treatment of chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Contributions to patient adherence: is it time to share the blame?

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Barriers to use of electronic adherence monitoring in an HIV clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Demographically corrected norms for the California Verbal Learning Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FYVTR-T8EV-3TQ6-QAJC

10.1310/YVTR-T8EV-3TQ6-QAJC

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference